TREACE JAMES T sold 4.6% of their position (50K shares) of TREACE MEDICAL CONCEPTS, INC. on the open market
Open‑market sale worth $1.01M — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 4 sales
Filed: 3/29/2024ACC: 0000950170-24-038822
Director
Since Apr 2021
-50K
Net shares
Net seller
$1.01M
Total sold
4
Open market trades
0B · 4S
4
Total transactions
50K disposed
Non-Derivative Transactions4
Common Stock
Direct
Shares
−46.50K
Price / share
$20.12
Trade value
$935.58K
% of position
4.3%
11/15/2022
1.09M→1.04M
Common Stock
Direct
Shares
−1.60K
Price / share
$21.18
Trade value
$33.89K
% of position
0.2%
11/15/2022
1.04M→1.04M
Common Stock
Direct
Shares
−200.00
Price / share
$21.97
Trade value
$4.39K
% of position
0.0%
11/15/2022
1.04M→1.04M
Common Stock
Direct
Shares
−1.70K
Price / share
$24.02
Trade value
$40.83K
% of position
0.2%
11/15/2022
1.04M→1.04M
Total
Net shares
−50K
Net value
-$1.01M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 11/15/2022 | S · Sale | −46.50K | $20.12 | $935.58K | 4.3% | 1.09M | 1.04M |
| Common Stock Direct | 11/15/2022 | S · Sale | −1.60K | $21.18 | $33.89K | 0.2% | 1.04M | 1.04M |
| Common Stock Direct | 11/15/2022 | S · Sale | −200.00 | $21.97 | $4.39K | 0.0% | 1.04M | 1.04M |
| Common Stock Direct | 11/15/2022 | S · Sale | −1.70K | $24.02 | $40.83K | 0.2% | 1.04M | 1.04M |
| Total | −50K | -$1.01M | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned556.18K
Total
556.18K indirect556.18K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 556.18K | Indirect |
| Total | 556.18K | 556.18K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported